Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 8/29/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Colin N. Scott

Wrong Dr. Colin N. Scott?

Consultant

Novartis Consumer Health
Phone: +41 ** *******  HQ Phone
Email: c***@***.com
Local Address: New York City, New York, United States
Novartis AG
Lichtstrasse 35
Basel, BS 4056
Switzerland

Company Description: Novartis AG is a Switzerland-based holding that, through its subsidiaries, is engaged in the research, development, manufacture and marketing of healthcare...   more
Background

Employment History

Education

  • M.D.
  • medical degree , pulmonology and infectious diseases
    Glasgow University
34 Total References
Web References
According to Colin Scott, ...
www.samedanltd.com [cached]
According to Colin Scott, Clinical Project Leader for Novartis Consumer Health, this should lead the industry to recognise long-term studies in later stages of development, primarily as an effective medical management tool (across a broad spectrum of chronic conditions). At the same time, "pharma needs to better understand how to reach out into largely untapped, close-knit and underserved patient communities, and work through independent pharmacies, charity clinics and community working groups," adds Scott.
...
www.sec.gov, 1 Feb 2011 [cached]
0001410581 Scott Colin C/O NOVABAY PHARMACEUTICALS, INC. 5980 HORTON STREET, SUITE 550 EMERYVILLE CA 94608 1 VP, Clinical Research and Dev
Emisphere Technologies, Inc. - Emisphere Receives Patent Covering Oral Parathyroid Hormone Composition With Lilly
ir.emisphere.com [cached]
In addition, Emisphere also announced the appointment of Colin N. Scott, M.D., to the position of Vice President, Clinical Affairs.
Dr. Scott brings over 20 years of clinical program development expertise in a variety of therapeutic areas to Emisphere, and will be responsible for overseeing the development of all clinical programs to obtain and maintain product registrations, and for the clinical development of the Company's platform drug delivery technology. Dr. Scott's experience includes managing, executing and designing clinical trials in all phases of development through pre-launch.
Dr. Scott joins Emisphere from Muro/ASTA Medica, Inc., a wholly owned subsidiary of the Rx-Healthcare Division of ASTA Medica AG, headquartered in Frankfurt, Germany, where he held the position of Director, Medical Affairs. Previously, Dr. Scott was Vice President, Clinical and Regulatory Affairs at CytoMed, Inc. Dr. Scott received his medical degree from Glasgow University, Scotland.
...
We are pleased that Dr. Scott has joined at this exciting time, to lead our efforts as we expand and advance multiple products into the clinic this year. His clinical affairs expertise will also help to establish a long-term clinical development strategy for our earlier-stage product candidates. We look forward to Dr. Scott's participation in creating the clinical infrastructure necessary to capture the potential of Emisphere's product pipeline."
PharmaLive
www.medadnews.com, 14 June 2001 [cached]
In addition , Emisphere also announced the appointment of Colin N. Scott , M.D. , to the position of Vice President , Clinical Affairs.
Dr. Scott brings over 20 years of clinical program development expertise in a variety of therapeutic areas to Emisphere , and will be responsible for overseeing the development of all clinical programs to obtain and maintain product registrations , and for the clinical development of the Company's platform drug delivery technology.Dr. Scott's experience includes managing , executing and designing clinical trials in all phases of development through pre-launch.
Dr. Scott joins Emisphere from Muro/ASTA Medica , Inc. , a wholly owned subsidiary of the Rx-Healthcare Division of ASTA Medica AG , headquartered in Frankfurt , Germany , where he held the position of Director , Medical Affairs.Previously , Dr. Scott was Vice President , Clinical and Regulatory Affairs at CytoMed , Inc..Dr. Scott received his medical degree from Glasgow University , Scotland.
Colin Scott, M.B., Ch.B., ...
www.novabaypharma.com, 19 Nov 2008 [cached]
Colin Scott, M.B., Ch.B., Vice President, Clinical Research and Development
Colin Scott, M.B., Ch.B., has served as NovaBay's Vice President, Clinical Research and Development since January 2006. Prior to joining NovaBay, Dr. Scott was the Vice President, Drug Development for GlycoMimetics.
Dr. Scott has held senior management roles at Arriva Pharmaceuticals, Inc., and Emisphere Technologies, Inc.
Dr. Scott received a medical degree in pulmonology and infectious diseases from Glasgow University in Scotland.
Other People with the name "Scott":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304